Cerevel Book Value Per Share from 2010 to 2024
| CERE Stock | USD 41.99 0.11 0.26% |
Book Value Per Share | First Reported 2010-12-31 | Previous Quarter 4.15747221 | Current Value 2.37 | Quarterly Volatility 1.77473968 |
Check Cerevel Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cerevel main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 12.6 M or Selling General Administrative of 107 K, as well as many exotic indicators such as Price To Sales Ratio of 39.33, Dividend Yield of 0.0 or PTB Ratio of 9.22. Cerevel financial statements analysis is a perfect complement when working with Cerevel Therapeutics Valuation or Volatility modules.
Cerevel | Book Value Per Share |
Latest Cerevel Therapeutics' Book Value Per Share Growth Pattern
Below is the plot of the Book Value Per Share of Cerevel Therapeutics Holdings over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Cerevel Therapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cerevel Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 3.71 X | 10 Years Trend |
|
Book Value Per Share |
| Timeline |
Cerevel Book Value Per Share Regression Statistics
| Arithmetic Mean | 2.39 | |
| Geometric Mean | 1.64 | |
| Coefficient Of Variation | 74.29 | |
| Mean Deviation | 1.54 | |
| Median | 2.32 | |
| Standard Deviation | 1.77 | |
| Sample Variance | 3.15 | |
| Range | 4.9255 | |
| R-Value | 0.13 | |
| Mean Square Error | 3.34 | |
| R-Squared | 0.02 | |
| Significance | 0.65 | |
| Slope | 0.05 | |
| Total Sum of Squares | 44.10 |
Cerevel Book Value Per Share History
Other Fundumenentals of Cerevel Therapeutics
Cerevel Therapeutics Book Value Per Share component correlations
Click cells to compare fundamentals
About Cerevel Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cerevel Therapeutics income statement, its balance sheet, and the statement of cash flows. Cerevel Therapeutics investors use historical funamental indicators, such as Cerevel Therapeutics's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Cerevel Therapeutics investors may use each financial statement separately, they are all related. The changes in Cerevel Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cerevel Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cerevel Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cerevel Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.16 | 2.37 | |
| Tangible Book Value Per Share | 4.16 | 4.37 |
Pair Trading with Cerevel Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cerevel Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Cerevel Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cerevel Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cerevel Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cerevel Therapeutics Holdings to buy it.
The correlation of Cerevel Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cerevel Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cerevel Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cerevel Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cerevel Therapeutics Correlation against competitors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Cerevel Stock analysis
When running Cerevel Therapeutics' price analysis, check to measure Cerevel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerevel Therapeutics is operating at the current time. Most of Cerevel Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cerevel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerevel Therapeutics' price. Additionally, you may evaluate how the addition of Cerevel Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Cerevel Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cerevel Therapeutics. If investors know Cerevel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cerevel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.67) | Return On Assets (0.25) | Return On Equity (0.72) |
The market value of Cerevel Therapeutics is measured differently than its book value, which is the value of Cerevel that is recorded on the company's balance sheet. Investors also form their own opinion of Cerevel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cerevel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cerevel Therapeutics' market value can be influenced by many factors that don't directly affect Cerevel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cerevel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cerevel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cerevel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.